Site icon OncologyTube

Awaiting Phase 3 for Luspatercept and ASTX727 Clinical trial accrual is an ongoing challenge in MDS

Marlise R. Luskin, MD, MSCE, Johns Hopkins University School of Medicine, discusses Awaiting Phase 3 for Luspatercept and ASTX727 Clinical trial accrual is an ongoing challenge in MDS at Imedex Great Debates 2018.

Exit mobile version